FNY Investment Advisers’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-500
Closed -$35K 900
2026
Q1
$35K Sell
500
-5,400
-92% -$416K 0.02% 410
2025
Q4
$468K Buy
5,900
+3,093
+110% +$244K 0.13% 150
2025
Q3
$211K Buy
2,807
+2,138
+320% +$147K 0.07% 264
2025
Q2
$46K Buy
+669
New +$43.9K 0.02% 416
2024
Q4
Sell
-3,286
Closed -$206K 707
2024
Q3
$206K Buy
+3,286
New +$192K 0.1% 166
2022
Q2
Sell
-982
Closed -$99K 740
2022
Q1
$99K Buy
+982
New +$103K 0.09% 175
2019
Q3
Sell
-600
Closed -$32K 933
2019
Q2
$32K Sell
600
-36,700
-98% -$1.98M 0.01% 420
2019
Q1
$2.01M Buy
37,300
+4,297
+13% +$265K 0.69% 25
2018
Q4
$2.16M Buy
+33,003
New +$2.46M 0.76% 27

Other funds holding CVS

FNY Investment Advisers's CVS Position: Q2 2026 in Review

FNY Investment Advisers sold out of CVS Health (CVS) in Q2 2026, closing a stake of 500 shares — an estimated $35K sold.

FNY Investment Advisers first reported a position in CVS in Q4 2018 and held it in 9 quarters. The position peaked at $2.16M in Q4 2018. 937 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • FNY Investment Advisers reported no remaining CVS Health position as of Q2 2026 after selling out during the quarter.
  • FNY Investment Advisers sold 500 CVS Health shares in Q2 2026, an estimated $35K.
  • FNY Investment Advisers first reported a position in CVS Health in Q4 2018 and held it in 9 quarters.
  • FNY Investment Advisers's CVS Health position peaked at $2.16M in Q4 2018.
  • 937 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.